Clemens PR - Search Results

1

Exon-Skipping in Duchenne Muscular Dystrophy.

Takeda S, Clemens PR, Hoffman EP. Takeda S, et al. Among authors: clemens pr. J Neuromuscul Dis. 2021;8(s2):S343-S358. doi: 10.3233/JND-210682. J Neuromuscul Dis. 2021. PMID: 34180420 Free PMC article. Review.

2

HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies.

Hoffman EP, Clemens PR. Hoffman EP, et al. Among authors: clemens pr. Curr Opin Rheumatol. 1996 Nov;8(6):528-38. doi: 10.1097/00002281-199611000-00006. Curr Opin Rheumatol. 1996. PMID: 9018456 Review.

3

Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors.

Feero WG, Rosenblatt JD, Huard J, Watkins SC, Epperly M, Clemens PR, Kochanek S, Glorioso JC, Partridge TA, Hoffman EP. Feero WG, et al. Among authors: clemens pr. Hum Gene Ther. 1997 Mar 1;8(4):371-80. doi: 10.1089/hum.1997.8.4-371. Hum Gene Ther. 1997. PMID: 9054512

4

Polylysine modification of adenoviral fiber protein enhances muscle cell transduction.

Bouri K, Feero WG, Myerburg MM, Wickham TJ, Kovesdi I, Hoffman EP, Clemens PR. Bouri K, et al. Among authors: clemens pr. Hum Gene Ther. 1999 Jul 1;10(10):1633-40. doi: 10.1089/10430349950017635. Hum Gene Ther. 1999. PMID: 10428208

5

Progress in gene therapy for Duchenne muscular dystrophy.

Clemens PR, Duncan FJ. Clemens PR, et al. Curr Neurol Neurosci Rep. 2001 Jan;1(1):89-96. doi: 10.1007/s11910-001-0080-0. Curr Neurol Neurosci Rep. 2001. PMID: 11898504 Review.

6

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Among authors: clemens pr. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.

7

Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene.

Koppanati BM, Li J, Reay DP, Wang B, Daood M, Zheng H, Xiao X, Watchko JF, Clemens PR. Koppanati BM, et al. Among authors: clemens pr. Gene Ther. 2010 Nov;17(11):1355-62. doi: 10.1038/gt.2010.84. Epub 2010 Jun 10. Gene Ther. 2010. PMID: 20535217 Free PMC article.

8

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM; Cooperative International Neuromuscular Research Group. Pegoraro E, et al. Neurology. 2011 Jan 18;76(3):219-26. doi: 10.1212/WNL.0b013e318207afeb. Epub 2010 Dec 22. Neurology. 2011. PMID: 21178099 Free PMC article.

9

Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. Pichavant C, et al. Among authors: clemens pr. Mol Ther. 2011 May;19(5):830-40. doi: 10.1038/mt.2011.59. Epub 2011 Apr 5. Mol Ther. 2011. PMID: 21468001 Free PMC article. Review.

10

In utero delivery of oligodeoxynucleotides for gene correction.

Cai L, Koppanati BM, Bertoni C, Clemens PR. Cai L, et al. Among authors: clemens pr. Methods Mol Biol. 2014;1114:399-411. doi: 10.1007/978-1-62703-761-7_26. Methods Mol Biol. 2014. PMID: 24557918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page